Psychiatry
RSSArticles
Many Ethical Questions if Psychiatric Patient Is Boarded in the ED
Psychiatric patients are routinely boarded in emergency departments for hours or even days, raising significant safety issues. There is growing concern about the ethical implications of this controversial practice.
Zuranolone Capsules (Zurzuvae)
Zuranolone can be prescribed to treat postpartum depression.
Postpartum Depression Medication Headed to Market
FDA approves first oral solution.
Antidepressants for Chronic Pain: Do They Work?
Antidepressant medications have been widely used for treating a variety of chronic pain disorders, but strong evidence to support their efficacy is lacking. Some patients may respond, but available data do not help us determine which agents may be helpful in a specific type of chronic pain condition.
Feds Propose to Strengthen Mental Health, Substance Use Treatment Access
The Biden administration wants better enforcement of a law that was designed to remove administrative barriers to receiving proper insurance coverage.
Prioritize Bed Placement for Older Patients to Shorten Stays, Prevent Delirium
A team of emergency physicians gathered data showing that among older patients, there is an association between time spent in the ED and the development of delirium. Researchers found that for every hour spent in the ED, the risk of developing delirium increased by roughly 2%.
Consensus Panel Offers Guidance for Pediatric Mental Health Boarding
EDs nationwide continue to see pediatric mental health patients boarded in the department for long periods while awaiting inpatient bed placement. A group of 23 experts from 17 health systems sought to identify what EDs are facing, to learn how departments are handling the problem, and to offer recommendations to standardize practices.
Boarded Mental Health Patients: Out of Sight, Out of Mind
Many EDs routinely board mental health patients for days on end, awaiting transfer to a mental health facility. An expert offers tips to help emergency medicine providers alleviate safety and medical/legal risks.
USPSTF Recommends Screening for Anxiety
The group suggests including all patients younger than age 65 years, calls for more study of screening older patients.
Feds Weigh In on Psychedelic Medicine Clinical Trials
FDA issues draft guidance for researchers studying alternative therapies.